{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:20:15Z","timestamp":1789518015417,"version":"build-2803163510"},"reference-count":47,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2011,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Although oral miltefosine represented an important therapeutic advance in the treatment of leishmaniasis, the appearance of resistance remains a serious threat. LMDR1\/LABCB4, a P-glycoprotein-like transporter included in the<jats:italic>Leishmania<\/jats:italic>ABC (ATP-binding cassette) family, was the first molecule shown to be involved in experimental miltefosine resistance. LMDR1 pumps drugs out of the parasite, thereby decreasing their intracellular accumulation. Sitamaquine, another promising oral drug for leishmaniasis, is currently in phase 2b clinical trials. The physicochemical features of this drug suggested to us that it could be considered for use as an LMDR1 inhibitor. Indeed, we report herein that nonleishmanicidal concentrations of sitamaquine reverse miltefosine resistance in a multidrug resistance<jats:italic>Leishmania tropica<\/jats:italic>line that overexpresses LMDR1. This reversal effect is due to modulation of the LMDR1-mediated efflux of miltefosine. In addition, sitamaquine is not a substrate of LMDR1, as this transporter does not affect sitamaquine accumulation or sensitivity in the parasite. Likewise, we show that ketoconazole, another oral leishmanicidal drug known to interact with ABC transporters, is also able to reverse LMDR1-mediated miltefosine resistance, although with a lower efficiency than sitamaquine. Molecular docking on a three-dimensional homology model of LMDR1 showed different preferential binding sites for each substrate-inhibitor pair, thus explaining this different behavior. Finally, we show that sitamaquine is also able to modulate the antimony resistance mediated by MRPA\/LABCC3, another ABC transporter involved in experimental and clinical antimony resistance in this parasite. Taken together, these data suggest that the combination of sitamaquine with miltefosine or antimony could avoid the appearance of resistance mediated by these membrane transporters in<jats:italic>Leishmania<\/jats:italic>.<\/jats:p>","DOI":"10.1128\/aac.00065-11","type":"journal-article","created":{"date-parts":[[2011,6,7]],"date-time":"2011-06-07T01:54:15Z","timestamp":1307411655000},"page":"3838-3844","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":51,"title":["Sitamaquine Overcomes ABC-Mediated Resistance to Miltefosine and Antimony in<i>Leishmania<\/i>"],"prefix":"10.1128","volume":"55","author":[{"given":"Jos\u00e9 M.","family":"P\u00e9rez-Victoria","sequence":"first","affiliation":[{"name":"Instituto de Parasitolog\u00eda y Biomedicina L\u00f3pez-Neyra, Consejo Superior de Investigaciones Cient\u00edficas (IPBLN-CSIC), Parque Tecnol\u00f3gico de Ciencias de la Salud, Avda. del Conocimiento s\/n, 18100 Armilla, Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris I.","family":"Bavchvarov","sequence":"additional","affiliation":[{"name":"Instituto de Parasitolog\u00eda y Biomedicina L\u00f3pez-Neyra, Consejo Superior de Investigaciones Cient\u00edficas (IPBLN-CSIC), Parque Tecnol\u00f3gico de Ciencias de la Salud, Avda. del Conocimiento s\/n, 18100 Armilla, Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n R.","family":"Torrecillas","sequence":"additional","affiliation":[{"name":"Laboratori de Medicina Computacional, Unitat de Bioestadistica, Universitat Aut\u00f2noma de Barcelona, 08193 Cerdanyola del Vall\u00e8s, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mart\u00ednez-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Instituto de Parasitolog\u00eda y Biomedicina L\u00f3pez-Neyra, Consejo Superior de Investigaciones Cient\u00edficas (IPBLN-CSIC), Parque Tecnol\u00f3gico de Ciencias de la Salud, Avda. del Conocimiento s\/n, 18100 Armilla, Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"L\u00f3pez-Mart\u00edn","sequence":"additional","affiliation":[{"name":"Instituto de Parasitolog\u00eda y Biomedicina L\u00f3pez-Neyra, Consejo Superior de Investigaciones Cient\u00edficas (IPBLN-CSIC), Parque Tecnol\u00f3gico de Ciencias de la Salud, Avda. del Conocimiento s\/n, 18100 Armilla, Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Campillo","sequence":"additional","affiliation":[{"name":"Laboratori de Medicina Computacional, Unitat de Bioestadistica, Universitat Aut\u00f2noma de Barcelona, 08193 Cerdanyola del Vall\u00e8s, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Castanys","sequence":"additional","affiliation":[{"name":"Instituto de Parasitolog\u00eda y Biomedicina L\u00f3pez-Neyra, Consejo Superior de Investigaciones Cient\u00edficas (IPBLN-CSIC), Parque Tecnol\u00f3gico de Ciencias de la Salud, Avda. del Conocimiento s\/n, 18100 Armilla, Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Gamarro","sequence":"additional","affiliation":[{"name":"Instituto de Parasitolog\u00eda y Biomedicina L\u00f3pez-Neyra, Consejo Superior de Investigaciones Cient\u00edficas (IPBLN-CSIC), Parque Tecnol\u00f3gico de Ciencias de la Salud, Avda. del Conocimiento s\/n, 18100 Armilla, Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2007.12.007"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2005.07.021"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2007.05653.x"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00587-08"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1021\/ci700257y"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(97)00385-7"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-6851(03)00162-2"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm0309699"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2009.07484.x"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature05155"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-002-8424-8"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2006.03.006"},{"key":"e_1_3_3_14_2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0031-6997(25)00045-6","article-title":"Pharmacology of drugs that alter multidrug resistance in cancer","volume":"42","author":"Ford J. M.","year":"1990","unstructured":"FordJ. M. HaitW. N.. 1990. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 42:155\u2013199.","journal-title":"Pharmacol. Rev"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/16.11.3057"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2006.05.009"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.2174\/092986709787458489"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012870904097"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00152-06"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M803351200"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2010.04.057"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.023267"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2008.02.025"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00964-08"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.58.3.624"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl494"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2006.04.001"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi982455v"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00423-06"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.2174\/1389450023347588"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10123-001-0031-2"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.2.439-446.2001"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.9.2468-2474.2001"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm991066b"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-4165(00)00160-4"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/35002615"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(96)00556-4"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1993.1626"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpara.2010.04.001"},{"key":"e_1_3_3_40_2","first-page":"686","article-title":"Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine","volume":"51","author":"Sangraula H.","year":"2003","unstructured":"SangraulaH. SharmaK. K. RijalS. DwivediS. KoiralaS.. 2003. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine. J. Assoc. Physicians India 51:686\u2013690.","journal-title":"J. Assoc. Physicians India"},{"key":"e_1_3_3_41_2","first-page":"57","article-title":"Python: a programming language for software integration and development","volume":"17","author":"Sanner M. F.","year":"1999","unstructured":"SannerM. F. 1999. Python: a programming language for software integration and development. J. Mol. Graph. Model. 17:57\u201361.","journal-title":"J. Mol. Graph. Model"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-010-9352-6"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.9.1.105"},{"key":"e_1_3_3_44_2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott O.","year":"2010","unstructured":"TrottO. OlsonA. J.. 2010. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31:455\u2013461.","journal-title":"J. Comput. Chem"},{"key":"e_1_3_3_45_2","first-page":"119","article-title":"Antifungal drug resistance in pathogenic fungi","volume":"36","author":"Vanden Bossche H.","year":"1998","unstructured":"Vanden BosscheH. . 1998. Antifungal drug resistance in pathogenic fungi. Med. Mycol. 36:119\u2013128.","journal-title":"Med. Mycol"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(00)00270-7"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0709388104"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2005.05.022"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00065-11","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00065-11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:33:02Z","timestamp":1741221182000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00065-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["10.1128\/AAC.00065-11"],"URL":"https:\/\/doi.org\/10.1128\/aac.00065-11","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"2011-01-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-05-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-07-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}